Health ❯ Healthcare ❯ Clinical Trials

Efficacy Studies

Patient Outcomes Phase 3 Trials Lecanemab Orforglipron Lecanemab Trials OASIS 4 Trial Phase 2 Trials Lenacapavir Efficacy Weight Loss Medications Weight Loss Efficacy Progression-Free Survival Edison Histotripsy System Lecanemab Trial Results LUNA 3 Study DREAMM-8 Trial Phase II Trials STEP Program Lecanemabe Acalabrutinib and Bendamustine-Rituximab Placebo-Controlled Trials MONARCH 2 Trial Hormone Receptor-Positive Cancer CAPELLA Trial ACCESS Program Obesity Treatments Adverse Events Drug Comparisons Orforglipron vs Semaglutide SELECT Trial Results POETYK PsA Trials Phase-3 Trials Weight Loss Trials STEP UP Trial Analytical Testing CheckMate 67T Non-Inferiority Trials Weight Loss Outcomes Long-term Data Semaglutide Trials Wegovy Oral Weight Management Minoxidil Absorption SUMMIT Trial STEP UP Trials Beamion LUNG-1 Trial ONWARDS Program ATTAIN-1 Trial Lenacapavir Randomized Trials Cagrilintide H3 K27M Mutations Pediatric Oncology Miplyffa AUGMENT-101 Trial MATTERHORN Trial Tirzepatide vs Dulaglutide Home Treatment Options Phase IIb/III Trials mNEXSPIKE Vaccine Lecanemab Efficacy SURMOUNT and SURPASS Amycretin Trials MONARCH 3 Trial Asthma Exacerbations Simplify-1 Study FRESCO Trials Antibody Response DEVOTE Study TRANSCEND FL Study Weight Loss Drugs Rezafungin

FDA Approves Auvelity as First Non‑Antipsychotic for Alzheimer’s Agitation

The approval reflects strong relapse‑prevention data from ACCORD‑2 over mixed acute results.

IDEAYA Combo Doubles Progression-Free Survival in Uveal Melanoma Trial

FDA Approves Higher‑Dose Spinraza Regimen for Spinal Muscular Atrophy

FDA Approves Awiqli, First Once-Weekly Basal Insulin for Type 2 Diabetes

Kodiak’s Zenkuda Hits Phase 3 Goal in Diabetic Retinopathy Prompting Faster FDA Filing

FDA Approves First Glucocorticoid Receptor Blocker for Platinum-Resistant Ovarian Cancer

Structure’s Oral Obesity Pill Delivers 16.3% Placebo-Adjusted Weight Loss in Phase 2

Biomea Fusion Reports Positive 52-Week Phase II Results for Icovamenib in Diabetes

FDA Approves Sotyktu for Active Psoriatic Arthritis as First TYK2 Inhibitor

EU Regulators Back First Combined COVID-19 and Flu mRNA Shot for Adults 50 and Over

FDA Clears GSK’s Exdensur as First Twice-Yearly Add-On for Severe Eosinophilic Asthma

EMA Panel Backs Higher 7.2 mg Wegovy Dose for Obesity

FDA Approves Breyanzi for Marginal Zone Lymphoma After Two or More Therapies

FDA Approves Durvalumab Added to Perioperative FLOT for Resectable Gastric and GEJ Cancer

FDA Approves Epkinly Monotherapy and Triplet Regimen for Relapsed Follicular Lymphoma

Stevia-Derived Microneedle Patch Boosts Minoxidil in Mouse Hair-Loss Study

FDA Approves Merck’s Enflonsia Monoclonal Antibody for Infant RSV Prevention

FDA Approves Moderna’s mNEXSPIKE for High-Risk Populations